New shot could zap skin cancer without surgery
NCT ID NCT07670858
First seen Jun 27, 2026 · Last updated Jun 30, 2026 · Updated 2 times
Summary
This early-phase trial tests an injected drug called FLD-103 for nodular basal cell carcinoma, a common skin cancer. About 48 adults will receive either one or several injections directly into their tumor. The main goal is to check safety and find the right dose, while also seeing if the injection shrinks the cancer.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
FLD-103 (injected into the tumor)
What this could lead to
If it works, this could lead to a new way to treat basal cell skin cancer without surgery.
What could go wrong
This is a very early, small trial (48 people) testing safety first. It may not shrink tumors or could cause side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NODULAR BASAL CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Equity Medical
RECRUITINGBowling Green, Kentucky, 42104, United States
-
Equity Medical
NOT_YET_RECRUITINGNew York, New York, 10023, United States
-
FNQH Cairns Skin Cancer Clinic
RECRUITINGWestcourt, Queensland, 4870, Australia
-
Innovate Clinical Research
RECRUITINGWaitara, New South Wales, 2077, Australia
-
Novatrials
RECRUITINGCharlestown, New South Wales, 2290, Australia
-
Scientia Clinical Research
RECRUITINGRandwick, New South Wales, 2031, Australia
-
Translational Research Institute
RECRUITINGWoolloongabba, Queensland, 4102, Australia
-
Veracity Clinical Research
RECRUITINGWoolloongabba, Queensland, 4102, Australia
-
Woden Dermatology
RECRUITINGPhillip, Australian Capital Territory, 2606, Australia